SSRIs may do more harm than good — and the data on women’s happiness makes it harder to ignore

In one version, they are life-saving medications that correct a chemical imbalance and allow people to return to themselves.

In the other version, they are overprescribed drugs that numb people into tolerating lives they should be questioning.

Neither version feels fully honest.

The truth is more uncomfortable: SSRIs can help. They can reduce unbearable anxiety and depression. They can create space where there was only panic, despair, or exhaustion. But they may also come with costs we do not talk about enough — especially when it comes to women.

Because women are not only more likely to experience depression and anxiety. They are also more likely to be prescribed antidepressants. In the United States, CDC data from 2015-2018 found that antidepressant use was more than twice as high among women as men: 17.7% compared with 8.4%.

That statistic alone does not prove anything sinister.

But it should make us pause.

Because at the same time, research on subjective well-being has raised a strange and painful question: why have women’s lives improved by many objective measures, while women’s happiness has not clearly followed the same path?

In their well-known paper, Betsey Stevenson and Justin Wolfers described a “paradox of declining female happiness”, finding that women’s subjective well-being had declined both absolutely and relative to men across multiple datasets and industrialized countries. More recent work on the gender well-being gap has also found that women tend to report higher negative affect and lower scores on many positive well-being measures across large international datasets.

So the question is not: Are SSRIs bad?

The question is harder than that.

Why are so many women suffering? And are we treating that suffering too privately?

When medication helps, but something still feels unresolved

I have taken an SSRI during a period of intense anxiety.

I took it because I needed relief. Not because I wanted to become perfectly happy. Not because I wanted to erase the difficult parts of being human. I just wanted my body to stop acting like danger was everywhere.

And it helped.

That is important to say.

It made me more functional. It softened the anxiety. It gave me enough distance from the storm inside my nervous system to move through the day again.

But I also remember feeling something I did not know how to explain at first. I felt calmer, but also less fully alive. More regulated, but also more mechanical. As if I had become better at functioning, but less able to touch the emotional depth underneath my own life.

I did not want the anxiety back. I still do not romanticize suffering.

But I began to wonder: what happens when a medication does not only reduce pain, but also quiets the emotional signals that might be trying to tell us something?

Sadness has a function. Anger has a function. Grief has a function. Even anxiety, as painful and irrational as it can become, sometimes points toward something real: a boundary crossed, a truth avoided, a life that no longer fits, a body that has been carrying too much for too long.

This is where the SSRI conversation becomes more complicated than “they work” or “they don’t.”

Maybe the question is also: what kind of suffering are they helping us tolerate?

Women’s distress is often treated as an individual problem

Women today are expected to be many things at once.

Independent, but emotionally available. Ambitious, but not selfish. Beautiful, but effortless. Caring, but not needy. Productive, but not burned out. Calm, but not detached. Strong, but still soft enough to hold everyone else together.

And much of this pressure remains invisible because it is framed as normal life.

Care work is one obvious example. The International Labour Organization estimated that in 2023, 708 million women worldwide were outside the labor force because of unpaid care responsibilities, compared with 40 million men. The OECD has also reported that women spend more hours in unpaid work than men, with consequences for earnings, careers, and social protection.

This matters for mental health.

Because if a woman is exhausted, anxious, emotionally numb, resentful, lonely, or overwhelmed, the easiest explanation is often individual: her brain chemistry, her coping skills, her hormones, her resilience, her diagnosis.

Sometimes that explanation is necessary. Sometimes clinical treatment is exactly what someone needs.

But sometimes it also hides the larger picture.

A woman may not be “malfunctioning.” She may be reacting to impossible demands.

She may be depressed because she is lonely. Anxious because she is overextended. Numb because she has had to suppress anger for years. Exhausted because she is performing competence in a life that gives her little space to collapse.

And if the first solution is always medication, we risk turning social pain into private pathology.

SSRIs may help symptoms, but functioning is not the same as healing

There is good evidence that antidepressants can reduce symptoms for many people. A major 2018 Lancet network meta-analysis of 21 antidepressants found that all included antidepressants were more effective than placebo for acute major depressive disorder in adults.

That matters.

For someone who cannot sleep, cannot get out of bed, cannot stop spiraling, or cannot function, symptom relief is not a small thing. It can be the difference between drowning and finally getting air.

But symptom relief is not the whole story.

A person can look “better” from the outside because she is calmer, more productive, and less visibly distressed. But inside, she may feel emotionally flattened. She may cry less, but also laugh less. She may feel less panic, but also less desire. She may become easier to manage without feeling more deeply connected to herself.

This is not just anecdotal. Emotional blunting is a widely discussed SSRI-related concern. In fact, emotional “blunting” is believed to affect 40-60% of patients taking SSRIs. A 2017 study on emotional blunting with antidepressant treatments also found that emotional blunting was reported by nearly half of depressed patients on antidepressants, while carefully noting that blunting can be difficult to separate from depression itself.

That nuance is important.

Not every case of emotional numbness is caused by medication. Depression itself can flatten a person’s emotional world. Anxiety can narrow life into survival. Trauma can disconnect people from feeling.

But if many patients report this experience while taking SSRIs, it deserves more attention than a casual warning on a side-effect list.

Especially for women.

Because women are already trained, in many ways, to mute themselves.

To not be too angry. To not be too much. To not make others uncomfortable. To keep functioning. To stay pleasant. To stay useful. To stay emotionally available, even when they are depleted.

In that context, emotional blunting is not just a side effect.

It becomes a cultural metaphor.

The serotonin story was never as simple as we were told

Part of the problem is the story many people absorbed about antidepressants.

For years, depression was popularly explained as a chemical imbalance, especially a serotonin deficiency. This explanation was simple, memorable, and reassuring. It helped reduce shame for many people by framing depression as biological rather than moral weakness.

But it was also incomplete.

A 2022 Molecular Psychiatry umbrella review concluded that the main areas of serotonin research do not provide consistent evidence that depression is caused by lowered serotonin activity or concentration.

This does not prove that SSRIs do not work.

That distinction matters. Critics of the Moncrieff review have argued that challenging the serotonin theory is not the same thing as disproving the clinical effects of antidepressants. A King’s College London response, for example, emphasized this distinction.

A medication can reduce symptoms even if the original public explanation for how it works was too simple.

But the review does make one thing harder to ignore: we may have told people a story about their suffering that was too narrow.

And when the story is too narrow, the treatment conversation becomes too narrow too.

If depression and anxiety are framed mainly as chemical problems, we may under-ask other questions.

What happened to this person?

What is her life asking of her?

Where is she unsupported?

What anger has she swallowed?

What grief has she had no time to feel?

What would have to change for her symptoms to make sense?

Medication may still be part of the answer. But it should not become the whole language of suffering.

What if women’s emotions are not the problem?

One of the most dangerous ideas in modern mental health culture is that emotional pain is always a symptom to eliminate.

Sometimes it is.

When anxiety becomes unbearable, when depression steals a person’s ability to live, when the nervous system is trapped in alarm, relief matters. Treatment matters. Medication can matter.

But not all pain is meaningless.

Anger may tell us where a boundary has been crossed. Sadness may tell us what we have lost. Grief may tell us what mattered. Anxiety may tell us that we are living too long in contradiction. Exhaustion may tell us that the body is refusing a pace the mind keeps trying to justify.

Of course, emotions are not always accurate. They can be distorted by trauma, stress, hormones, sleep deprivation, and fear. But that does not mean they are useless. They are not glitches in the machine. They are part of how a human being knows herself.

So when many women are medicated for distress, we have to ask carefully: are we helping them heal, or helping them adapt?

Are we reducing suffering, or reducing protest?

Are we treating depression, or making unbearable lives feel more bearable?

There is no single answer. For some women, SSRIs may be genuinely life-restoring. For others, they may be a temporary bridge. For others, they may bring relief while also creating emotional distance from the very signals that needed attention.

The problem is not that SSRIs exist.

The problem is that our culture often prefers functional women to honest ones.

The real question is not whether women should take SSRIs

No one should be shamed for taking medication. No one should be told to stop. Decisions about antidepressants should be made with a qualified professional, especially because stopping suddenly can be harmful.

But we can hold that truth and still ask bigger questions.

Why are so many women anxious and unhappy?

Why is burnout treated as a personal regulation problem?

Why do we ask women to meditate, medicate, journal, optimize, and self-improve before we ask whether their lives have become emotionally impossible?

Why is a woman’s distress so quickly translated into a disorder, but so rarely treated as information?

SSRIs may help many people. They may help women survive periods of life that would otherwise feel unbearable. But survival is not the same as healing. Calm is not always peace. Functioning is not always freedom.

Sometimes, the goal should not be to make a woman quieter. Sometimes, the goal should be to help her hear herself more clearly.

SSRIs are not the enemy. But a culture that treats women’s pain only as a private chemical problem might be.

Because the most human parts of us are not always the calmest ones.

Sometimes they are the sad parts. The angry parts. The grieving parts. The anxious parts that keep whispering, long before we are ready to listen:

Something has to change.